Epitomics Signs Antibody Development Agreement with the National Cancer Institute
December 15, 2010
Burlingame, CA - Epitomics and NCI to Develop Novel Antibodies Using Epitomics Technology Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) [...]
New Business Win Is Perfect Chemistry For Science Warehouse
December 15, 2010
Science Warehouse, one of the fastest growing companies in the e-business sector, has won a major new contract with leading international group of laboratories, Eurofins Scientific. Science Warehouse, one of the fastest growing companies in the e-business sector, has won a major new contract with leading international group of laboratories, Eurofins Scientific. The agreement sees [...]
Picarro, Inc. Moves to New R&D and Production Facility
December 15, 2010
Picarro, the maker of the world’s leading instruments for carbon, water and nitrogen cycle measurement, today announced the company is moving to new state-of-the-art manufacturing and R&D facilities in Santa Clara, California. The move is part of Picarro’s rapid expansion into new product lines and new business verticals, as well as an ongoing expansion of [...]
December 15, 2010
GRAND RAPIDS, Mich. - X-Rite, Incorporated (NASDAQ:XRIT) today announced that both Moody's Investors Service (Moody’s) and Standard & Poor's Ratings Services (S&P) recently upgraded their respective corporate credit ratings on X-Rite. Moody's upgraded X-Rite’s corporate family rating to B2 from B3, and the rating on the first lien senior secured credit facilities to B1 from [...]
December 15, 2010
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that its SureSelect Target Enrichment System now supports the 454 Life Sciences next-generation sequencing platform, boosting efficiency and cost-effectiveness of research by enabling users to sequence just genomic regions of interest rather than entire genomes. "The SureSelect Target Enrichment Kits are now optimized and [...]
Genovis Has Signed Distribution Agreement with ADVANSYS Technologies for Life Ltd
December 15, 2010
Genovis, a producer of new technologies used for Imaging and Antibody Engineering, today announced that it has entered into an agreement with ADVANSYS Technologies for Life Ltd. to exclusive distribute its products on the Israeli market. Genovis provides novel technical solutions for Imaging and Antibody Engineering. The objectives are to maintain a strong, collaborative and [...]
WaferGen Announces $7 Million Capital Raise
December 15, 2010
Fremont, Calif. - WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that its Malaysian subsidiary, WaferGen Biosystems (M) Sdn. Bhd., has signed a purchase agreement with an investor for a $5 million private placement of the Malaysian subsidiary’s Series C-1 redeemable convertible preference shares. WaferGen also announced that it [...]
Affymetrix Announces Court Order Directing Dismissal of Illumina Patent Infringement Lawsuits
December 15, 2010
SANTA CLARA, Calif. - Affymetrix, Inc. (NASDAQ:AFFX) (the "Company") today announced that the U.S. District Court for the Western District of Wisconsin (the "Court") has granted the company's motion for summary judgment that Affymetrix does not infringe the patents held by Illumina, Inc. (NASDAQ: ILMN), and has directed that the patent infringement lawsuits brought against [...]
Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study
December 15, 2010
SAN DIEGO - Sequenom, Inc. (Nasdaq: SQNM) today announced the acceptance of a manuscript describing results from the R&D "locked-assay" verification study conducted by the company's wholly-owned subsidiary, Sequenom Center for Molecular Medicine. Details of this study entitled "Noninvasive Detection of Fetal Trisomy 21 by Plasma DNA Sequencing in a Clinical Setting" have been embargoed [...]
Promega Joins United Nations Global Compact as Part of Corporate Sustainability Program
December 15, 2010
MADISON, WISCONSIN - Promega Corporation reinforces its commitment to socially responsible business practices on a worldwide basis by signing the United Nations Global Compact. The UN Global Compact is a policy initiative for businesses that are committed to supporting the Compact's ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption. [...]

